Hossein Sadrzadeh MD.

Dr. Hossein Sadrzadeh is an internationally recognized hematologist, oncologist, and visionary co-founder and CEO of Nick Health. With a mission to raise the global standard of cancer care,

​​​

Dr. Sadrzadeh blends clinical expertise, groundbreaking research, and entrepreneurial drive to reshape the cancer journey. His relentless pursuit of proactive, personalized, and accessible care aims to set new global benchmarks in patient-centered, research-driven oncology. " As an Oncologist Working at Top-tier Cancer Centers, also Receiving Second Opinion Requests Globally, I’ve Seen Even the Best Systems Leave Patients Feeling Unsupported Beyond Treatment Rooms." – Dr. Hossein Sadrzadeh –

Dr. Sadrzadeh's career spans Harvard Medical School, Boston University, and the Dana-Farber Cancer Institute, where he has led advancements in oncology, particularly in hematologic malignancies and cell therapy. A prolific researcher and thought leader.

Dr. Sadrzadeh has published widely in leading journals and presented at global conferences. His expertise is sought worldwide, earning him invitations to international symposiums, television appearances, and global forums to share his insights on cancer innovation. From immigrant trainee to Harvard physician and industry disruptor, Dr. Sadrzadeh's journey reflects resilience, passion, and an unyielding commitment to empower patients and transform cancer care.  His personal connection to the cancer journey fuels his mission to build Nick Health into a global force for compassionate, next-generation cancer support and advocacy.E